Aeromide 200 µg Inhaler
PDF Leaflet Revision Date: 15 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis of asthma symptoms.
Dosage (summary)
Initial: 400 u03bcg daily; max: 1600 u03bcg.
Special Populations
- Hepatic impairment
- Children
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A inhibitors
- Oestrogens
Contraindications
- Hypersensitivity to budesonide
- Active pulmonary tuberculosis
- Untreated infections
Common side effects
- Oropharyngeal candidiasis
- Pneumonia
- Psychotic behaviour
- Local irritation
Counselling Points
- Rinse mouth after use
- Use bronchodilator before inhaler
- Do not stop abruptly
Serious warnings
- Adrenal suppression
- Paradoxical bronchospasm
- Systemic corticosteroid effects
Important Disclaimer
The Aeromide 200 µg Inhaler professional information leaflet below is the property of Forrester Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
